📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia. (2023)

First Author: Barber VS

Attributed to: COVID-19 Immunity - National Core Study (IMM-NCS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2023-077946

PubMed Identifier: 37770269

Publication URI: http://europepmc.org/abstract/MED/37770269

Type: Journal Article/Review

Volume: 13

Parent Publication: BMJ open

Issue: 9

ISSN: 2044-6055